LEADER 01110nam0 22002893i 450 001 VAN0107855 005 20230615022434.675 010 $a978-33-19-12528-2 017 70$2N$a978-3-319-12529-9 100 $a20170215d2015 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aˆThe ‰Art of Regression Modeling in Road Safety$fEzra Hauer 210 $aCham$cSpringer$d2015 215 $axvii, 231 p.$d24 cm 620 $aCH$dCham$3VANL001889 700 1$aHauer$bEzra$3VANV083234$0720968 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240614$gRICA 856 4 $uhttps://link.springer.com/book/10.1007/978-3-319-12529-9$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN0107855 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 575 $e15EB 575 20170215 996 $aArt of Regression Modeling in Road Safety$91413092 997 $aUNICAMPANIA LEADER 03830nam 2200661Ia 450 001 9910966686103321 005 20251017110051.0 010 $a0-309-15135-X 010 $a1-282-50135-6 010 $a9786612501357 010 $a0-309-14576-7 035 $a(CKB)2550000000010479 035 $a(EBL)3378590 035 $a(SSID)ssj0000425571 035 $a(PQKBManifestationID)11285363 035 $a(PQKBTitleCode)TC0000425571 035 $a(PQKBWorkID)10367984 035 $a(PQKB)11669130 035 $a(MiAaPQ)EBC3378590 035 $a(Au-PeEL)EBL3378590 035 $a(CaPaEBR)ebr10370368 035 $a(CaONFJC)MIL250135 035 $a(OCoLC)923281442 035 $a(DNLM)1534378 035 $a(EXLCZ)992550000000010479 100 $a20100301d2010 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aPolicy issues in the development of personalized medicine in oncology $eworkshop summary /$fMargie Patlak and Laura Levit, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$dc2010 215 $a1 online resource (95 p.) 300 $a" ... the National Cancer Policy Forum held a workshop, "Policy Issues in the Development of Personalized Medicine in Oncology," in Washington, DC, on June 8 and 9, 2009."--P. 1. 311 08$a0-309-14575-9 320 $aIncludes bibliographical references (p. 65-70). 327 $a""Front Matter""; ""Reviewers""; ""Contents""; ""Introduction""; ""Personalized Cancer Medicine Technology""; ""Regulation of Predictive Tests""; ""Reimbursement""; ""Summary""; ""References""; ""Acronyms""; ""Glossary""; ""Appendix A: Workshop Agenda""; ""Appendix B: Workshop Speakers and Moderators"" 330 $a"One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of individuals will be given preventive or therapeutic interventions based on their susceptibility to a particular disease or their predicted response to a specific treatment. However, before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of technological, regulatory, and reimbursement issues. To explore these policy challenges, the National Cancer Policy Forum held the workshop Policy Issues in the Development of Personalized Medicine in Oncology in June 2009. Experts provided presentations on the current state of personalized medicine technology, as well as issues in the validation of, regulation of, and reimbursement for the predictive tests that underpin personalized medicine. Participants discussed the obstacles and possible solutions to further developing and using personalized medicine technologies. This document summarizes the workshop."--Publisher's description. 606 $aCancer$xTreatment$zUnited States 606 $aMedical care$zUnited States 606 $aMedical policy$zUnited States 615 0$aCancer$xTreatment 615 0$aMedical care 615 0$aMedical policy 676 $a616.994 701 $aLevit$b Laura A$01810851 701 $aPatlak$b Margie$01607028 712 02$aInstitute of Medicine (U.S.).$bBoard on Health Care Services. 712 02$aNational Cancer Policy Forum (U.S.) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910966686103321 996 $aPolicy issues in the development of personalized medicine in oncology$94445871 997 $aUNINA